Skip to main content
. Author manuscript; available in PMC: 2022 May 14.
Published in final edited form as: Circ Res. 2021 May 13;128(10):1533–1553. doi: 10.1161/CIRCRESAHA.121.318346

TABLE2.

Categorization of the Genetic Variant for Clinical Applications in HCM

Category Definition Characteristics
PVs Variants for which there is a strong genetic evidence for their involvement in the pathogenesis of HCM
  • PVs are predicted to distort structure and function of the encoded proteins, often leading to premature truncation of the protein and haplo-insufficiency

  • Frameshift variants, such as indels and splice junction variants

  • Variants leading to gain or loss of a stop codon

  • Missense variants with a high CADD score

  • Rare in the general population

  • Typically involve genes that are intolerant to LoF variants

LPVs As for PVs, except that genetic evidence for their involvement in the pathogenesis of HCM is less robust
  • LPVs have characteristics similar to those of the PVs

  • Typically they involve genes that are partially intolerant to LoF variants

Functional variants with undefined clinical significance Variants affect gene expression and/or protein function but are not associated with a clinical phenotype
  • Relatively common in the genome

  • Functional effects at the mRNA and/or protein levels

  • Involve genes that are tolerant to LoF variants

Variants with unknown significance Undefined functional or clinical significance
  • Common in the genome

  • Often located in intergenic regions or introns

Likely benign variants These variants are not expected to cause discernible phenotypic effects. They might have modest effects on gene expression but are not related to HCM
  • Common in the general population

  • Are not predicted to exert functional or clinical effects

Benign variants Variants with no discernible functional, biological, or clinical effects
  • Common in the general population

  • These variants are expected to be inconsequential at the functional and clinical levels

Abbreviations:

PVs: Pathogenic variants; LPVs: Likely pathogenic variants; LoF: Predicted loss of function; CADD: Combined Annotated Dependent Depletion, which is a score calculated upon integration of more than 60 genomic features of single nucleotide variants and indels.